Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

NCT03849560 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
612
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NPO Petrovax